Back
Meta Platforms, Inc. Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Sell
47
META
Meta Platforms, Inc.
Last Price:
$662.26
Seasonality Move:
8.82%
Sell
42
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$21.03
Seasonality Move:
10.38%
Sell
47
Meta Platforms, Inc. (META)
is a Sell
Is Meta Platforms, Inc. a Buy, Sell or Hold?
-
The current Meta Platforms, Inc. [META] share price is $658.77. The Score for META is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
META is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.04. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
META Stock Price Chart
What is Meta Platforms, Inc.'s stock price today?
-
The Meta Platforms, Inc. share price today is $658.77The current trend is relatively stagnant and META is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $21.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
META Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.98 | Buy |
| Relative Strength Index (14 RSI): | 53.32 | Buy |
| Chaikin Money Flow: | -45376979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (611.49 - 662.47) | Buy |
| Bollinger Bands (100): | (648.78 - 766.2) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 51.11 | Buy |
| Chaikin Money Flow: | 1527880 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.4 - 22.24) | Buy |
| Bollinger Bands (100): | (17.55 - 22.19) | Buy |
META Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 653.06 | Buy |
| 20-day SMA: | 646.79 | Buy |
| 50-day SMA: | 661.2 | Sell |
| 200-day SMA: | 671.26 | Sell |
| 8-day EMA: | 655.07 | Buy |
| 20-day EMA: | 649.96 | Buy |
| 50-day EMA: | 662.78 | Sell |
| 200-day EMA: | 667.44 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.48 | Sell |
| 20-day SMA: | 21.06 | Sell |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 32.06 | Sell |
| 8-day EMA: | 11.03 | Buy |
| 20-day EMA: | 5.4 | Buy |
| 50-day EMA: | 2.36 | Buy |
| 200-day EMA: | 0.62 | Buy |
Meta Platforms, Inc. Earnings Growth & META Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.30 per share, and an increase next year of $5.14 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.60 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.03 per share, and an increase next year of $4.91 per share.
Meta Platforms, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||